The importance of beta-adrenergic receptors in immune regulation: A link between neuroendocrine and immune system

Medical Hypotheses

Volumn 56, Issue 3, 2001, Pages 273-276

  Xu, Biying ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR;

ADRENERGIC SYSTEM; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; GENE STRUCTURE; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPHOCYTE; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL;

EID: 0035028842     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2000.1127     Document Type: Article

References (47)

1. Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins
2. The role of skeletal muscle - β-adrenoceptors in the regulation of plasma potassium
3. Cyclic AMP in skeletal muscle
4. The effects of adrenaline, noradrenaline and isoprenaline on skeletal muscle contractions in cat
5. Actions of sympathomimetic amines and their antagonists on skeletal muscle
6. Effect of epinephrine muscle glycogenolysis during exercise in trained men
7. β-adrenergic receptors in heart failure
8. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy
9. Adrenoceptor genes in human obesity
10. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function
11. Catecholamine-induced adipocyte lyolysis in human hyperthyroidism
12. Increased lymphocyte β-adrenergic receptor density in progressive multiple sclerosis is specific for the CD8+, CD28- suppressor cell
13. β-adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: A regulatory role for cortisol and interleukin-1
14. Decreased β-adrenergic receptor density on peripheral blood mononuclear cells in myasthenia gravis
15. Decreased density of β2-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis
16. Correlation between density of 2-adrenergic receptors on peripheral blood mononuclear cells and serum levels of soluble interleukin-2 receptors in patients with chronic inflammatory diseases
17. Adaptive regulation of β-adrenergic receptors in children with insulin dependent diabetes mellitus
18. Decreased β2-adrenoceptor density and decreased isoproterenol induced c-AMP increase in juvenile type I diabetes mellitus: An additional cause of severe hypoglycemia in childhood diabetes?
19. Antibodies against beta-1 and beta-2 adrenergic receptors in myasthenia gravis
20. Beta-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats
21. The beta 2-adrenergic agonist terbutaline suppresses acute passive transfer experimental autoimmune myasthenia gravis (EAMG)
22. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: Mechanisms of action
23. A new method for isolation of human lymphocyte subsets reveals differential regulation of β-adrenergic receptors by terbutaline treatment
24. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes
25. β-adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes
26. Anti-inflammatory activity of salmeterol: Down-regulation of cytokine production
27. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production
28. IL-12 production by central nervous system microglia is inhibited by astrocytes
29. Inhibition of IFN-γ induction of class II MHC genes by cyclic AMP and prostaglandins
30. Regulation of tumour necrosis factor production by mouse peritoneal macrophages: The role of cellular cyclic AMP
31. Release of tumor necrosis factor-α from macrophages enhancement of suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides
32. Cyclic AMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction
33. Activation of the interleukin-5 promoter by cyclic AMP in murine EL-4 cells requires the GATA-3 and CLEO elements
34. Synthesis of interleukin 6 (interferon-β2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP
35. Up-regulation of monocytic IL-10 by tumour necrosis factor-α and cyclic AMP elevating drugs
36. Anti-inflammatory activities of cyclic AMP-elevating agents: Enhancement of IL-10 synthesis and concurrent suppression of TNF production
37. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help
38. Genetics of β2-adrenergic receptor variants in asthma
39. Polymorphisms of the 2-adrenergic receptor and asthma
40. Mutations in the gene encoding for the 2-adrenergic receptor in normal and asthmatic subjects
41. Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics
42. Association of hypertension with β2- and α2c10-adrenergic receptor genotype
43. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function
44. β2-adrenergic receptor gene polymorphisms in myasthenia gravis
45. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF in RNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype
46. Drosophila larval neuromuscular junction's responses to reduction of cyclic AMP in the nervous system
47. The association between Trp64Arg Polymorphism of the beta3-adrenergic receptor and autonomic nervous system activity